24.06.2013 • News

Statements: Business Strategy

Company

Bodo Möller Chemie

Company contact

I am interested in:

an offer
a callback
detailed information

Your request

salutation first name last name

country phone email

Please note our data protection information for the contact form.

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download

Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

Expert Insights

ADCs for Precision Cancer Therapy

Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Top-Feature

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Predictive Simulation in Pharma Production

most read

News • Chemistry

Jens Birgersson Becomes New Brenntag CEO

Jens Birgersson becomes new Brenntag CEO

News • Strategy

Ratcliffe: Chemical Industry in Europe at a Tipping Point

Ineos CEO Ineos calls on European politicians to save the chemical industry.

News • Chemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.

News • Chemistry

BASF Sells Majority Stake in Coatings Business

BASF sells a majority stake in its coatings business to the investor Carlyle.

News • Bioprocessing

Merck Acquires Chromatography Business from JSR Life Sciences

Merck to acquire the chromatography business of JSR Life Sciences, a leading provider of CDMO services, preclinical and translational clinical research, and bioprocessing solutions.